Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-19
2007-06-19
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S275000, C544S331000
Reexamination Certificate
active
10821382
ABSTRACT:
The present invention relates to phenylaminopyrimidine derivatives, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states such as cancers associated with tyrosine kinases, especially Bcr-Abl, to their use as medicaments and to their use in the manufacture of medicaments for use in the production of inhibition of tyrosine kinase reducing effects in warm-blooded animals such as humans.
REFERENCES:
patent: WO 2004/029038 (2004-04-01), None
patent: WO 2004/099186 (2004-11-01), None
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
LandOfFree
Phenylaminopyrimidine derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylaminopyrimidine derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylaminopyrimidine derivatives and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3864736